Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-001760-38Phase 3Completed
Phase 3 trial of levothyroxine sodium in hypothyroidism (2 arms), sponsored by Uni-Pharma. Primary endpoint: Equivalence of FT4 and TSH concentrations between liquid and tablet levothyroxine. Started Jun 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-001760-38.